\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ lower\\ lobectomy\\ and\\ lymphnode\\ biopsy\\.\ \(0\)\
\-\ solitary\\ 1\\.4\\ cm\\ pulmonary\\ nodule\\ in\\ the\\ superior\\ segment\\ of\\ the\\ right\\ lower\\ lobe\\ with\\ moderate\\ fdg\\ metabolic\\ activity\\.\\ \\ additional\\ intermediate\\ fdg\\ metabolic\\ activity\\ in\\ a\\ 6mm\\ right\\ hilar\\ lymph\\ node\\.\ \(0\)\
\-\ adenocarcinoma\\ of\\ the\\ lung\\,\\ poorly\\ to\\ moderately\\ undifferentiated\\.\ \(0\)\
\-\ neoplasia\ \(18\)\
\-\ \\<li\\>bronchogenic\\ ca\ \(1\)\
\-\ \\<li\\>metastasis\ \(3\)\
\-\ inflammatory\ \(375\)\
\-\ \\<li\\>reactive\\ nodule\ \(1\)\
\-\ \\<li\\>granulomatous\\ process\ \(1\)\
\-\ 36\\ yo\\ male\\ marathon\\ runner\\ and\\ no\\ prior\\ history\\ of\\ tobbaco\\ use\\ found\\ to\\ have\\ pulmonary\\ nodule\\ on\\ chest\\ x\\-ray\\ evaluation\\ for\\ progressive\\ shortness\\ of\\ breath\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.4516541133068507\ \(0\)\
\-\ nodule\\:\\ 0\\.2819709747391289\ \(0\)\
\-\ fdg\\:\\ 0\\.2579388600752426\ \(0\)\
\-\ metabolic\\:\\ 0\\.21590411160311127\ \(0\)\
\-\ tobbaco\\:\\ 0\\.19043554508229094\ \(0\)\
\-\ activity\\:\\ 0\\.17485361477808326\ \(0\)\
\-\ lymphnode\\:\\ 0\\.1675016585923496\ \(0\)\
\-\ marathon\\:\\ 0\\.16149620237922202\ \(0\)\
\-\ runner\\:\\ 0\\.15303198724081515\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.151361069856159\ \(0\)\
\-\ pulmonary\\:\\ 0\\.145170034075895\ \(0\)\
\-\ neoplasia\\:\\ 0\\.14343910138915575\ \(0\)\
\-\ lobectomy\\:\\ 0\\.14037870649750236\ \(0\)\
\-\ 6mm\\:\\ 0\\.1325568596761531\ \(0\)\
\-\ lower\\:\\ 0\\.12170046836191087\ \(0\)\
\-\ intermediate\\:\\ 0\\.12163388561246698\ \(0\)\
\-\ moderately\\:\\ 0\\.12014215665079465\ \(0\)\
\-\ right\\:\\ 0\\.11844027726768039\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.11449975868608685\ \(0\)\
\-\ hilar\\:\\ 0\\.10919253890371862\ \(0\)\
\-\ solitary\\:\\ 0\\.10898060486915417\ \(0\)\
\-\ poorly\\:\\ 0\\.10755441857702959\ \(0\)\
\-\ granulomatous\\:\\ 0\\.10585322515646144\ \(0\)\
\-\ node\\:\\ 0\\.10235195840472036\ \(0\)\
\-\ reactive\\:\\ 0\\.10219902495073903\ \(0\)\
\-\ ca\\:\\ 0\\.1015982547672115\ \(0\)\
\-\ 36\\:\\ 0\\.0985715351903333\ \(0\)\
\-\ segment\\:\\ 0\\.09831695492418087\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.0973285893590809\ \(0\)\
\-\ shortness\\:\\ 0\\.09548205387471527\ \(0\)\
\-\ of\\:\\ 0\\.09321405897394644\ \(0\)\
\-\ lymph\\:\\ 0\\.09259812092225657\ \(0\)\
\-\ additional\\:\\ 0\\.09231149871105328\ \(0\)\
\-\ progressive\\:\\ 0\\.09120281394772577\ \(0\)\
\-\ use\\:\\ 0\\.09111302747338716\ \(0\)\
\-\ moderate\\:\\ 0\\.08939392300658751\ \(0\)\
\-\ process\\:\\ 0\\.08931157448519617\ \(0\)\
\-\ metastasis\\:\\ 0\\.08727716285502123\ \(0\)\
\-\ breath\\:\\ 0\\.08727716285502123\ \(0\)\
\-\ biopsy\\:\\ 0\\.0834711414484601\ \(0\)\
\-\ inflammatory\\:\\ 0\\.08052117578698866\ \(0\)\
\-\ superior\\:\\ 0\\.07741914045996932\ \(0\)\
\-\ found\\:\\ 0\\.07705047175052579\ \(0\)\
\-\ yo\\:\\ 0\\.07439470286913957\ \(0\)\
\-\ evaluation\\:\\ 0\\.07262193185411372\ \(0\)\
\-\ lung\\:\\ 0\\.07243800711276534\ \(0\)\
\-\ the\\:\\ 0\\.07128258697584584\ \(0\)\
\-\ lobe\\:\\ 0\\.06881591044755259\ \(0\)\
\-\ cm\\:\\ 0\\.06838924665601198\ \(0\)\
\-\ prior\\:\\ 0\\.06662571455377343\ \(0\)\
\-\ chest\\:\\ 0\\.0628566897419241\ \(0\)\
\-\ to\\:\\ 0\\.05953975144101866\ \(0\)\
\-\ have\\:\\ 0\\.0594872107905805\ \(0\)\
\-\ in\\:\\ 0\\.05924669690773703\ \(0\)\
\-\ male\\:\\ 0\\.053019192049907425\ \(0\)\
\-\ and\\:\\ 0\\.049213029447870524\ \(0\)\
\-\ history\\:\\ 0\\.04549562116813991\ \(0\)\
\-\ no\\:\\ 0\\.0387236036232734\ \(0\)\
\-\ for\\:\\ 0\\.036092367011519806\ \(0\)\
\-\ on\\:\\ 0\\.03596433641637992\ \(0\)\
\-\ with\\:\\ 0\\.02331743858799292\ \(0\)\
